Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina Inc
(NQ:
ILMN
)
132.10
+2.77 (+2.14%)
Streaming Delayed Price
Updated: 1:31 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
28
29
Next >
What Does Illumina's Debt Look Like?
June 30, 2023
Via
Benzinga
Looking Into Illumina's Recent Short Interest
June 29, 2023
Via
Benzinga
Creative Biolabs’ Innovative Microbial Identification Solutions Propel Live Biotherapeutic Research
June 28, 2023
Via
Get News
Illumina Unusual Options Activity For June 28
June 28, 2023
Via
Benzinga
Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?
June 26, 2023
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) initiated layoffs within its research and development (R&D) team, affecting approximately 10% of that staff.
Via
Benzinga
S&P 500: Carnival, Tesla Headline Big-Cap Losers Monday
June 26, 2023
Carnival rebounded from its 21-day, while Tesla is tumbling toward it.
Via
Investor's Business Daily
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $140 Thousand Today
June 22, 2023
Via
Benzinga
Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?
June 20, 2023
Things aren't looking up just yet.
Via
The Motley Fool
Illumina CEO Steps Down; Grail Soap Opera Continues
June 16, 2023
And we interview Anjay Nagpal, host of the podcast "Brokers, Bagmen, and Moles."
Via
The Motley Fool
Ominous Death Cross Forms On Illumina's Chart
June 15, 2023
Via
Benzinga
CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership
June 25, 2023
New CEOs and other top managers can revitalize companies. For example, here are seven stocks to gain momentum from leadership changes.
Via
InvestorPlace
Medical Stocks Waters, Agilent, Illumina Show Growth Potential
June 20, 2023
Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts.
Via
MarketBeat
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
3 Gene Testing Stocks to Buy Before They Take Off
June 17, 2023
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.
Via
InvestorPlace
Nephroblastoma Pipeline, NDA Approvals, Clinical Trials, and Emerging Drugs (2023) | Companies – Clarity Pharma, Y mAbs Therapeutics, Nova Biopharma, Eli Lilly, Illumina Radiopharma, Recombio and Other
June 16, 2023
Via
AB Newswire
Expert Ratings for Illumina
June 12, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
June 06, 2023
Via
Benzinga
Check Out What Whales Are Doing With ILMN
May 25, 2023
Via
Benzinga
Illumina's Grail Acquisition Gains Support from GOP Lawmakers and Advocacy Groups Despite FTC Resistance
June 14, 2023
Republican lawmakers, state attorneys general, and several advocacy groups have expressed their support for Illumina Inc's (NASDAQ: ILMN) acquisition of Grail Inc, even as the Federal Trade Commission...
Via
Benzinga
Is CEO Resignation a Sign That Carl Icahn Can Save Illumina (ILMN) Stock?
June 12, 2023
The CEO of Illumina has stepped down due to pressure form Carl Icahn. ILMN stock has already started rising on the news.
Via
InvestorPlace
Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories
June 12, 2023
Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger
Via
Benzinga
Executive Shakeup at Illumina: CEO Francis deSouza Steps Down Amid Activist Investor Carl Icahn's Pressure
June 12, 2023
Illumina Inc (NASDAQ.
Via
Benzinga
Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
June 12, 2023
Via
Benzinga
Apple's Upcoming VR Headset Marks Significant New Product Debut In Almost 10 Years, Regulators Want Tighter Capital Requirements For Large US Banks, Software Configuration Error at Grail Causes Cancer Misdiagnosis: Today's Top Stories
June 05, 2023
Wall Street Journal
Via
Benzinga
Software Configuration Error at Grail Causes Cancer Misdiagnosis Scare; Could It Impact Illumina's Acquisition Plans?
June 05, 2023
Illumina Inc's (NASDAQ: ILMN) Grail Inc acquisition is reportedly in more hot water when Grail mistakenly sent form letters to 400 patients, suggesting they may have developed cancer.
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
Elon Musk Praises Quality of Made in China Teslas, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay: Today's Top Stories
June 02, 2023
Benzinga
Via
Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
June 02, 2023
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 25, 2023
Via
Benzinga
Bill Ackman Thinks Rival Icahn's Firm Still Overvalued, Nvidia Nears $1 Trillion Market Cap, Freshpet's Largest Shareholder Pushes For Board Overhaul: Today's Top Stories
May 25, 2023
Benzinga
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.